FAH and maleylacetoacetate isomerase deficiency: We suggest that confirmatory testing after abnormal NBS for HT1 should include a work-up for MAAI deficiency in cases with a persistent—albeit slight—elevation of succinylacetone without the detection of biallelic pathogenic variants in the FAH gene [17].